<DOC>
	<DOCNO>NCT01082861</DOCNO>
	<brief_summary>Rationale : In march 2009 Dutch Health Council advise introduce general infant hepatitis B ( HBV ) vaccination Dutch national immunization program ( NIP ) { Gezondheidsraad 2009 # 16914 } . To reach anticipated health benefit earlier , catch-up vaccination pre-adolescents complement program , girl preferably combine human papillomavirus ( HPV ) vaccination age 12 year . Although rationale clear , particular aspect combine HPV HBV vaccination deserve attention , especially show combine HPV HBV vaccination result reduce HBV immunogenicity/seroresponses { Wheeler , Bautista , et al . 2008 # 17284 } { Pedersen 2009 # 16684 } . The reason interference unknown , might due concomitant use different antigen and/or adjuvant , possibly skew immunity opposite direction . Despite proven immunostimulatory effect , use ( new ) adjuvant raise safety concern among general public well { Israeli , Agmon-Levin , et al . 2009 # 16924 } . Objective , Study design Study population : In view observation concern mention , investigation interference HPV HBV vaccination adjuvant use justify . In context RIVM propose study single v simultaneous HBV HPV vaccination 11-12-year-old girl monitor antigen-related antigen-unrelated immunological parameter . The anticipated result elucidate extent interference simultaneous HPV HBV vaccination target group , guide choice HBV vaccine schedule HBV catch-up program indeed introduce . Furthermore , specific immunological trend post single combine HPV HBV vaccination elucidate , increase investigator comprehension adjuvant use .</brief_summary>
	<brief_title>Efficacy Immunomodulation Study Simultaneous Human Papillomavirus/ Hepatitis B ( HPV/HBV ) Vaccination</brief_title>
	<detailed_description />
	<mesh_term>Papillomavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Female preadolescents born 1998 , eligible HPV vaccination 2011 . 2 . Able fulfill study requirement . 1 . Previous vaccination license experimental HPV HBV vaccine . 2 . Contraindication vaccination Cervarix® . 3 . Contraindication vaccination EngerixB® . 4 . Use investigational vaccine medication within 30 day study 5 . History severe adverse reaction associate vaccine vaccine component . 6 . Heart disease 7 . Liver disease 8 . Spleen removal 9 . Asthma 10 . Immune deficiency suppression</criteria>
	<gender>Female</gender>
	<minimum_age>11 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>1998 female birth cohort eligible HPV vaccination 2011 within Dutch NIP</keyword>
</DOC>